Package leaflet: Information for the user

Similar documents
Package leaflet: Information for the user. Prandin 0.5 mg tablets Prandin 1 mg tablets Prandin 2 mg tablets. Repaglinide

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

SIOFOR mg film-coated tablets

1. What Betahistine dihydrochloride tablets is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Package leaflet: Information for the user

PACKAGE LEAFLET. Page 1 of 6

Package leaflet: Information for the user. Fluvastatin

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

SIOFOR mg film-coated tablets

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

Package leaflet: Information for the patient

Package leaflet: Information for the user

Package leaflet: Information for the user. GLUCOPHAGE 500 mg powder for oral solution in sachets metformin hydrochloride

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

2. What you need to know before you take Bisoprolol Tablets

Package leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

Package leaflet: Information for the patient. Onglyza 2.5 mg film-coated tablets Onglyza 5 mg film-coated tablets Saxagliptin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

PACKAGE LEAFLET Page 1 of 8

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

1. What Solpadol is and what it is used for

Package leaflet: Information for the patient

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Pravat 40 mg tablets. Pravastatin sodium

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

DIPRIAN 80 mg Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Irbenida H 150mg/12,5mg film-coated tablets

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Mylan 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

Package leaflet: Information for the User

Package leaflet: Information for the patient. Moventig 12.5 mg film-coated tablets Moventig 25 mg film-coated tablets. naloxegol

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

TREANA 5mg and 10mg Film-coated Tablets

SINGULAIR JUNIOR 5mg chewable tablets

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)

Package Leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.

PACKAGE LEAFLET. Page 1 of 8

Package leaflet: Information for the user. CYPROSTAT 50 mg tablet cyproterone acetate

Package leaflet: Information for the patient. Ezetimibe 10 mg tablets ezetimibe

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine)

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

Package leaflet: Information for the patient

Lochol XL 80 mg Prolonged-release Tablets

Motens 2 mg and 4 mg Tablets lacidipine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

Package leaflet: Information for the user

Package leaflet: Information for the patient. Janumet 50 mg/1,000 mg film-coated tablets sitagliptin/metformin hydrochloride

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Package leaflet: Information for the user. Cinfalair 4 mg chewable tablets montelukast

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package leaflet: Information for the patient. Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril)

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

PATIENT INFORMATION LEAFLET

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets

What is in this leaflet

Transcription:

Package leaflet: Information for the user Repaglinide Accord 0.5 mg tablets Repaglinide Accord 1 mg tablets Repaglinide Accord 2 mg tablets Repaglinide Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Repaglinide Accord is and what it is used for 2. What you need to know before you take Repaglinide Accord 3. How to take Repaglinide Accord 4. Possible side effects 5. How to store Repaglinide Accord 6. Contents of the pack and other information 1. What Repaglinide Accord is and what it is used for Repaglinide Accord is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose). Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces. Repaglinide Accord is used to control type 2 diabetes in adults as an add-on to diet and exercise: treatment is usually started if diet, exercise and weight reduction alone have not been able to control (or lower) your blood sugar. Repaglinide Accord can also be given with metformin, another medicine for diabetes. Repaglinide Accord has been shown to lower the blood sugar, which helps to prevent complications from your diabetes. 2. What you need to know before you take Repaglinide Accord Do not take Repaglinide Accord If you are allergic to repaglinide or any of the other ingredients in this medicine(listed in section 6). If you have type 1 diabetes. If the acid level in your blood is raised (diabetic ketoacidosis). If you have a severe liver disease. If you take gemfibrozil (a medicine used to lower increased fat levels in the blood). 1

Warnings and precautions Talk to your doctor before taking Repaglinide Accord If you have liver problems. Repaglinide Accord is not recommended in patients with moderate liver disease. Repaglinide Accord should not be taken if you have a severe liver disease (see Do not take Repaglinide Accord). If you have kidney problems. Repaglinide Accord should be taken with caution. If you are about to have major surgery or you have recently suffered a severe illness or infection. At such times diabetic control may be lost. If you are under 18 or over 75 years of age. Repaglinide Accord is not recommended. It has not been studied in these age groups. Talk to your doctor ifany of the above applies to you. Repaglinide Accord may not be suitable for you. Your doctor will advise you. Children and adolescents Do not take this medicine if you are under 18 years of age. If you get a hypo(low blood sugar) You may get a hypo (short for hypoglycaemia) if your blood sugar gets too low. This may happen: If you take too much Repaglinide Accord If you exercise more than usual If you take other medicines or suffer from liver or kidney problems (see other sections of 2. What you need to know before you take Repaglinide Accord). The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating. If your blood sugar is low or you feel a hypo coming on: eat glucose tablets or a high sugar snack or drink, then rest. When symptoms of hypoglycaemia have disappeared or when blood sugar levels are stabilised continue Repaglinide Accord treatment. Tell people you have diabetes and that if you pass out (become unconscious) due to a hypo, they must turn you on your side and get medical help straight away. They must not give you any food or drink. It could choke you. If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death. If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor. The amount of Repaglinide Accord, food or exercise may need to be adjusted. If your blood sugar gets too high Your blood sugar may get too high (hyperglycaemia). This may happen: If you take too little Repaglinide Accord If you have an infection or a fever If you eat more than usual If you exercise less than usual. 2

The warning signs of too high blood sugar appear gradually. They include: increased urination; feeling thirsty; dry skin and dry mouth. Talk to your doctor. The amount of Repaglinide Accord, food or exercise may need to be adjusted. Other medicines and Repaglinide Accord Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. You can take Repaglinide Accord with metformin, another medicine for diabetes, if your doctor prescribes it. If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take Repaglinide Accord. Your body s response to Repaglinide Accord may change if you take other medicines, especially these: Monoamine oxidase inhibitors (MAOI) (used to treat depression) Beta blockers (used to treat high blood pressure or heart conditions) ACE-inhibitors (used to treat heart conditions) Salicylates (e.g. aspirin) Octreotide (used to treat cancer) Nonsteroidal anti-inflammatory drugs (NSAID) (a type of painkillers) Steroids (anabolic steroids and corticosteroids used for anemia or to treat inflammation) Oral contraceptives (birth control pills) Thiazides (diuretics or water pills ) Danazol (used to treat breast cysts and endometriosis) Thyroid products (used to treat low levels of thyroid hormones) Sympathomimetics (used to treat asthma) Clarithromycin, trimethoprim, rifampicin (antibiotic medicines) Itraconazole, ketokonazole (antifungal medicines) Gemfibrozil (used to treat high blood fats) Ciclosporin (used to suppress the immune system) Deferasirox (used to reduce chronic iron overload) Clopidogrel (prevents blood clots) Phenytoin, carbamazepine, phenobarbital (used to treat epilepsy) St. John s wort (herbal medicine). Repaglinide Accord with alcohol Alcohol can change the ability of Repaglinide Accord to reduce the blood sugar. Watch for signs of a hypo. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. You should not take Repaglinide Accord if you are pregnant or you are planning to become pregnant. You should not take Repaglinide Accord if you are breast-feeding. Driving and using machines 3

Your ability to drive or use a machine may be affected if your blood sugar is low or high. Bear in mind that you could endanger yourself or others. Please ask your doctor whether you can drive a car if you: Have frequent hypos Have few or no warning signs of hypos. 3. How to take Repaglinide Accord Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure. Your doctor will work out your dose. The normal starting dose is 0.5 mg before each main meal. Swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal. The dose may be adjusted by your doctor by up to 4 mg to be taken immediately before or up to 30 minutes before each main meal. The maximum recommended daily dose is 16 mg. Do not take more Repaglinide Accord than your doctor has recommended. If you take more Repaglinide Accord than you should If you take too many tablets, your blood sugar may become too low, leading to a hypo. Please see If you get a hypo on what a hypo is and how to treat it. If you forget to take Repaglinide Accord If you miss a dose, take the next dose as usual - do not double the dose. If you stop taking Repaglinide Accord Be aware that the desired effect is not achieved if you stop taking Repaglinide Accord. Your diabetes may get worse. If any change of your treatment is necessary contact your doctor first. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Hypoglycaemia The most frequent side effect is hypoglycaemia which may affect up to 1 in 10 patients (see If you get a hypo in section 2). Hypoglycaemic reactions are generally mild/moderate but may occasionally develop into hypoglycaemic unconsciousness or coma. If this happens, medical assistance is needed immediately. Allergy Allergy is very rare (may affect up to 1 in 10,000 patients). Symptoms such as swelling, difficulty in breathing, rapid heartbeat, feeling dizzy and sweating could be signs of anaphylactic reaction. Contact a doctor immediately. Other side effects Common (may affect up to 1 in 10 patients) Stomach pain Diarrhoea. 4

Rare (may affect up to 1 in 1,000 patients) Acute coronary syndrome (but it may not be due to the medicine). Very rare (may affect up to 1 in 10,000 patients) Vomiting Constipation Visual disturbances Severe liver problems, abnormal liver functionsuch as increased liver enzymes in your blood. Frequency not known Hypersensitivity (such as rash, itchy skin, redening of the skin, swelling of the skin) Feeling sick (nausea). Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Repaglinide Accord Keep this medicine out of the sight and reach of children. Do not use Repaglinide Accord after the expiry date which is stated on the carton bottle label and blister after EXP. The expiry date refers to the last date of that month. This medicine does not require any special storage conditions. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Repaglinide Accord contains The active substance is repaglinide. Repaglinide Accord 0.5 mg:each tablet contains 0.5 mg repaglinide Repaglinide Accord 1 mg:each tablet contains 1 mg repaglinide Repaglinide Accord 2 mg:each tablet contains 2 mg repaglinide The other ingredients are microcrystalline cellulose, anhydrous calcium hydrogen phosphate, maize starch, meglumine, poloxamer 188, povidone, glycerin, magnesium stearate, yellow iron oxide (E172) only in the 1 mg tablets and red iron oxide (E172) only in the 2 mg tablets. What Repaglinide Accord looks like and contents of the pack The Repaglinide Accord 0.5 mg tablet is white to off white, round, biconvex, with beveled edge, with inscription R on one side and plain on other side. 5

The Repaglinide Accord 1 mg tablet is light yellow to yellow round, biconvex, with beveled edge, with inscription 'R' on one side and plain on other side, may have mottled appearance. The Repaglinide Accord 2 mg tablet is peach coloured, round, biconvex with beveled edge, with inscription 'R' on one side and plain on other side, may have mottled appearance Repaglinide Accord is available in the following pack sizes: 30, 90, 120, 180 or 270 tablets in blisters 100 tablets in a HDPE bottle. Not all pack sizes may be marketed. Marketing authorisation holder and manufacturer Accord Healthcare Limited, Sage house, 319 Pinner road, Harrow, HA1 4HF United Kingdom This leaflet was last revised in 09/2016. Other sources of information Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu 6